3.22.2 html 98 169 1 true 34 0 false 5 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Interim Balance Sheet (Current Period Unaudited) Sheet http://www.acastipharma.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimBalanceSheetCurrentPeriodUnaudited Condensed Consolidated Interim Balance Sheet (Current Period Unaudited) Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) Sheet http://www.acastipharma.com/20220630/taxonomy/role/StatementCondensedConsolidatedInterimStatementsOfLossAndComprehensiveLossUnaudited Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Interim Statements of Changes in Shareholder's Equity (Unaudited) Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-condensed-consolidated-interim-statements-of-changes-in-shareholders-equity-unaudited Condensed Consolidated Interim Statements of Changes in Shareholder's Equity (Unaudited) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Interim Statements of Cash Flows (Unaudited) Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-condensed-consolidated-interim-statements-of-cash-flows-unaudited Condensed Consolidated Interim Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 100050 - Disclosure - Note 1 - Nature of Operation Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-note-1-nature-of-operation Note 1 - Nature of Operation Notes 6 false false R7.htm 100060 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 7 false false R8.htm 100070 - Disclosure - Note 3 - Recent Accounting Pronouncements Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-note-3-recent-accounting-pronouncements Note 3 - Recent Accounting Pronouncements Notes 8 false false R9.htm 100080 - Disclosure - Note 4 - Intangible Assets Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote4IntangibleAssets Note 4 - Intangible Assets Notes 9 false false R10.htm 100090 - Disclosure - Note 5 - Short-term Investments Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-note-5-shortterm-investments- Note 5 - Short-term Investments Notes 10 false false R11.htm 100100 - Disclosure - Note 6 - Assets Held for Sale Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote6AssetsHeldForSale Note 6 - Assets Held for Sale Notes 11 false false R12.htm 100120 - Disclosure - Note 7 - Capital and Other Components of Equity Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote7CapitalAndOtherComponentsOfEquity Note 7 - Capital and Other Components of Equity Notes 12 false false R13.htm 100130 - Disclosure - Note 8 - Government Assistance Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote8GovernmentAssistance Note 8 - Government Assistance Notes 13 false false R14.htm 100150 - Disclosure - Note 9 - Net Financial Income Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote9NetFinancialIncome Note 9 - Net Financial Income Notes 14 false false R15.htm 100160 - Disclosure - Note 10 - Stock Based Compensation Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote10StockBasedCompensation Note 10 - Stock Based Compensation Notes 15 false false R16.htm 100170 - Disclosure - Note 11 - Supplemental Cash Flow Disclosure Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote11SupplementalCashFlowDisclosure Note 11 - Supplemental Cash Flow Disclosure Notes 16 false false R17.htm 100180 - Disclosure - Note 12 - Commitments and Contingencies Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote12CommitmentsAndContingencies1 Note 12 - Commitments and Contingencies Notes 17 false false R18.htm 100190 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.acastipharma.com/20220630/taxonomy/role/statement-note-2-summary-of-significant-accounting-policies 18 false false R19.htm 100200 - Disclosure - Note 4 - Intangible Assets (Tables) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote4IntangibleAssetsTables Note 4 - Intangible Assets (Tables) Tables http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote4IntangibleAssets 19 false false R20.htm 100210 - Disclosure - Note 5 - Short-term Investments (Tables) Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-note-5-shortterm-investments-tables Note 5 - Short-term Investments (Tables) Tables http://www.acastipharma.com/20220630/taxonomy/role/statement-note-5-shortterm-investments- 20 false false R21.htm 100220 - Disclosure - Note 6 - Assets Held for Sale (Tables) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote6AssetsHeldForSaleTables Note 6 - Assets Held for Sale (Tables) Tables http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote6AssetsHeldForSale 21 false false R22.htm 100230 - Disclosure - Note 7 - Capital and Other Components of Equity (Tables) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote7CapitalAndOtherComponentsOfEquityTables Note 7 - Capital and Other Components of Equity (Tables) Tables http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote7CapitalAndOtherComponentsOfEquity 22 false false R23.htm 100240 - Disclosure - Note 9 - Net Financial Income (Tables) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote9NetFinancialIncomeTables Note 9 - Net Financial Income (Tables) Tables http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote9NetFinancialIncome 23 false false R24.htm 100250 - Disclosure - Note 10 - Stock Based Compensation (Tables) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote10StockBasedCompensationTables Note 10 - Stock Based Compensation (Tables) Tables http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote10StockBasedCompensation 24 false false R25.htm 100260 - Disclosure - Note 11 - Supplemental Cash Flow Disclosure (Tables) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote11SupplementalCashFlowDisclosureTables Note 11 - Supplemental Cash Flow Disclosure (Tables) Tables http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote11SupplementalCashFlowDisclosure 25 false false R26.htm 100270 - Disclosure - Note 1 - Nature of Operation (Details Textual) Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-note-1-nature-of-operation-details-textual Note 1 - Nature of Operation (Details Textual) Details http://www.acastipharma.com/20220630/taxonomy/role/statement-note-1-nature-of-operation 26 false false R27.htm 100280 - Disclosure - Note 4 - Intangible Assets (Details Textual) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote4IntangibleAssetsDetailsTextual Note 4 - Intangible Assets (Details Textual) Details http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote4IntangibleAssetsTables 27 false false R28.htm 100290 - Disclosure - Note 4 - Intangible Assets - Schedule of Intangible Assets in Process Research and Development (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote4IntangibleAssetsScheduleOfIntangibleAssetsInProcessResearchAndDevelopmentDetails Note 4 - Intangible Assets - Schedule of Intangible Assets in Process Research and Development (Details) Details 28 false false R29.htm 100300 - Disclosure - Note 5 - Short-term Investments - Marketable Securities (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-note-5-shortterm-investments-marketable-securities-details Note 5 - Short-term Investments - Marketable Securities (Details) Details 29 false false R30.htm 100310 - Disclosure - Note 5 - Short-term Investments - Marketable Securities (Details) (Parentheticals) Sheet http://www.acastipharma.com/20220630/taxonomy/role/statement-note-5-shortterm-investments-marketable-securities-details-parentheticals Note 5 - Short-term Investments - Marketable Securities (Details) (Parentheticals) Details 30 false false R31.htm 100320 - Disclosure - Note 6 - Assets Held for Sale - Summary of Assets Held for Sale (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote6AssetsHeldForSaleSummaryOfAssetsHeldForSaleDetails Note 6 - Assets Held for Sale - Summary of Assets Held for Sale (Details) Details 31 false false R32.htm 100330 - Disclosure - Note 6 - Assets Held For Sale (Additional Information) (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote6AssetsHeldForSaleAdditionalInformationDetails Note 6 - Assets Held For Sale (Additional Information) (Details) Details 32 false false R33.htm 100340 - Disclosure - Note 7 - Capital and Other Components of Equity (Details Textual) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote7CapitalAndOtherComponentsOfEquityDetailsTextual Note 7 - Capital and Other Components of Equity (Details Textual) Details http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote7CapitalAndOtherComponentsOfEquityTables 33 false false R34.htm 100350 - Disclosure - Note 7 - Capital and Other Components of Equity - Warrants (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote7CapitalAndOtherComponentsOfEquityWarrantsDetails Note 7 - Capital and Other Components of Equity - Warrants (Details) Details http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote7CapitalAndOtherComponentsOfEquityTables 34 false false R35.htm 100360 - Disclosure - Note 8 - Government Assistance (Details Textual) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote8GovernmentAssistanceDetailsTextual Note 8 - Government Assistance (Details Textual) Details http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote8GovernmentAssistance 35 false false R36.htm 100370 - Disclosure - Note 9 - Net Financial Income - Financial Income (Expenses) (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote9NetFinancialIncomeFinancialIncomeExpensesDetails Note 9 - Net Financial Income - Financial Income (Expenses) (Details) Details 36 false false R37.htm 100380 - Disclosure - Note 10 - Stock Based Compensation (Details Textual) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote10StockBasedCompensationDetailsTextual Note 10 - Stock Based Compensation (Details Textual) Details http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote10StockBasedCompensationTables 37 false false R38.htm 100390 - Disclosure - Note 10 - Stock Based Compensation - Activities Within the Stock Option Plan (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote10StockBasedCompensationActivitiesWithinTheStockOptionPlanDetails Note 10 - Stock Based Compensation - Activities Within the Stock Option Plan (Details) Details 38 false false R39.htm 100400 - Disclosure - Note 10 - Stock-based Compensation - Schedule of fair value of options granted (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote10StockbasedCompensationScheduleOfFairValueOfOptionsGrantedDetails Note 10 - Stock-based Compensation - Schedule of fair value of options granted (Details) Details 39 false false R40.htm 100410 - Disclosure - Note 10 - Stock Based Compensation - Compensation Expense (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote10StockBasedCompensationCompensationExpenseDetails Note 10 - Stock Based Compensation - Compensation Expense (Details) Details 40 false false R41.htm 100420 - Disclosure - Note 11 - Supplemental Cash Flow Disclosure - Changes in Working Capital Items (Details) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote11SupplementalCashFlowDisclosureChangesInWorkingCapitalItemsDetails Note 11 - Supplemental Cash Flow Disclosure - Changes in Working Capital Items (Details) Details 41 false false R42.htm 100430 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) Sheet http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote12CommitmentsAndContingenciesDetailsTextual Note 12 - Commitments and Contingencies (Details Textual) Details http://www.acastipharma.com/20220630/taxonomy/role/DisclosureNote12CommitmentsAndContingencies1 42 false false All Reports Book All Reports acst-20220630.htm acst-20220630.xsd acst-20220630_cal.xml acst-20220630_def.xml acst-20220630_lab.xml acst-20220630_pre.xml acst-ex31_1.htm acst-ex31_2.htm acst-ex32_1.htm acst-ex32_2.htm img179496299_0.jpg img179496299_1.jpg img179496299_10.jpg img179496299_11.jpg img179496299_2.jpg img179496299_3.jpg img179496299_4.jpg img179496299_5.jpg img179496299_6.jpg img179496299_7.jpg img179496299_8.jpg img179496299_9.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true